Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
TransMedics Group NASDAQ TMDX
$87.86 -5.45 -6.20%
Today share price
USA
Sector: Industry:
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.00B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
3.12B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.91
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
34.18M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
11.31 %
Upcoming events TransMedics Group All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart TransMedics Group

Stock analysis TransMedics Group

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-119.98 -0.38
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
21.89 1.14
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-152.39 0.46
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-5.55 0.38
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-18.24 -21.27

Price change TransMedics Group per year

11.64$ 49.50$
Min Max

Summary analysis TransMedics Group

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure TransMedics Group

Revenue and net income TransMedics Group

All parameters
Stock news TransMedics Group All news
14 July 2021 в 17:39

TransMedics Group's stock is halted in advance of FDA committee meeting

About company TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Address:
200 Minuteman Road, Andover, MA, United States, 01810
Company name: TransMedics Group
Issuer ticker: TMDX
ISIN: US89377M1099
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-05-02
Site: https://www.transmedics.com

On which stock exchange are TransMedics Group (TMDX) stocks traded?

TransMedics Group (TMDX) stocks are traded on NASDAQ.

What is the ticker of TransMedics Group stocks (TMDX)?

The stock ticker of TransMedics Group’s stocks or in other words, the code is TMDX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does TransMedics Group (TMDX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, TransMedics Group (TMDX) belongs to the «» sector and the «» industry.

In what currency are TransMedics Group (TMDX) stocks traded?

TransMedics Group (TMDX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of TransMedics Group (TMDX) stocks today?

The current price of TransMedics Group stocks on 18.04.2024 is 87.86 dollars. per share.

What is the dynamics of TransMedics Group (TMDX) stocks from the beginning of the year?

TransMedics Group (TMDX) quotes have increased by 14.4% from the beginning of the year up to 87.86 dollars. per 1 stocks.

How much did TransMedics Group (TMDX) stocks increase in апреле 2024?

This month TransMedics Group (TMDX) quotes have increased by 19.65% to 87.86 dollars. per share.

How much are TransMedics Group (TMDX) stocks worth?

Today, on October, 18.04.2024 TransMedics Group’s (TMDX) stocks cost 87.86 dollars..

What is the market capitalization of TransMedics Group (TMDX)?

Capitalization is the market value of TransMedics Group (TMDX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.04.2024, the market capitalization of TransMedics Group (TMDX) is estimated at about 3002972124 dollars.